Evidence map›Paper›PMID 34602774›Full record

ArticleBioinformation2021

Molecular docking analysis of flupenthixol and desmethylastemizole with the apoptotic regulator proteins CFLAR and TRAF2 linked to lung carcinoma.

Subrata Das, Anupam Das Talukdar, Rajat Nath, Deepa Nath, Ashikur Rahaman, Shamee Bhattacharjee, Manbendra Dutta Choudhury

Open access · hybridAbstract read
In one paragraph

Article in Bioinformation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Subrata DasDepartment of Life Science and Bioinformatics, Assam University, Silchar-788011, India.
Anupam Das TalukdarDepartment of Life Science and Bioinformatics, Assam University, Silchar-788011, India.
Rajat NathDepartment of Life Science and Bioinformatics, Assam University, Silchar-788011, India.
Deepa NathDepartment of Botany, Gurucharan College, Silchar 4, Assam, India.
Ashikur RahamanDepartment of Zoology, West Bengal State University, Berunanpukuria, Malikapur, North 24 Parganas, Barasat, Kolkata-700126, West Bengal, India.
Shamee BhattacharjeeDepartment of Zoology, West Bengal State University, Berunanpukuria, Malikapur, North 24 Parganas, Barasat, Kolkata-700126, West Bengal, India.
Manbendra Dutta ChoudhuryDepartment of Life Science and Bioinformatics, Assam University, Silchar-788011, India.
Assam University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is known that molecular changes in apoptotic genes due to mutation may cause disruption of apoptotic pathway resulting in an abrupt increase in cell proliferation. Therefore, it is of interest to identify compounds that could potentially replenish the changes in the apoptotic pathway, resulted from mutation. The gene network analysis using the Network Analyzer Plugin of Cytoscape (3.5.1) shows CFLAR and TRAF2 as influential genes in the apoptotic pathway. Mutation in these genes brings loss in apoptotic property of a cell and thus increases the cell proliferating activity. Thus, data on the molecular docking analysis of four natural compounds from Ottelia alismoides (L.) Pers with the two target proteins were reported. Flupenthixol and desmethylastemizole was found to be two efficient ligand molecules based on ligand-target interaction. In stereochemical quality assessment, the Ramachandran plot analysis of receptors indicates the better stereochemical characteristics for receptor-ligand interaction.

Indexed as

apoptosisCFLARlung carcinomaMolecular dockingmutationTRAF2

Identifiers

PMID34602774
PMCPMC8450155
OpenAlexW3165674733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.